PATENT CLAIM ANALYSIS

Application Number: 16362962
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-10
Patent Classification: ["530", "387300"]

Abstract:
The present invention relates to antibodies against human CSF-1R (anti-CSF-1R antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.

Claim (Index 12):
A pharmaceutical composition comprising the antibody according to  claim 11 .

Metadata:
- Claim Count in Document: 50.0
- Percentile: 99.0
- Lexical Diversity: 1.11538
- Patent Class: 530.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15849743', '14527097', '15875530', '16055947', '15292710']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8290136146872278
- 35 USC 102 Novelty (BERT): 0.7393551296195523
- Combined Prediction Score: 0.8200477661804603
- Mean Citation Score: 829.479736
- Max Citation Score: 834.26074
- Similarity Product: 814.5120330981827

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test